510(k) K252689

MEDRAD Centargo CT Injection System; MEDRAD Centargo Day Set; MEDRAD Centargo Patient Line; MEDRAD Centargo Replacement Spike; MEDRAD ISI2 Module (ISI2) by Imaxeon Pty, Ltd. — Product Code IZQ

K252689 is an FDA 510(k) premarket notification submitted by Imaxeon Pty, Ltd. for the device "MEDRAD Centargo CT Injection System; MEDRAD Centargo Day Set; MEDRAD Centargo Patient Line; MEDRAD Centargo Replacement Spike; MEDRAD ISI2 Module (ISI2)". The FDA issued a decision of Substantially Equivalent on Sep 24, 2025. The device falls under product code IZQ (Injector, Contrast Medium, Automatic), a Class II device regulated under 21 CFR 870.1650. Imaxeon Pty, Ltd. has 1 other 510(k) clearance on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Sep 24, 2025
Date Received
Aug 26, 2025
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Injector, Contrast Medium, Automatic
Device Class
Class II
Regulation Number
870.1650
Review Panel
HO
Submission Type
510(k)

Need the full FDA record for Imaxeon Pty, Ltd.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K252689. Report a data issue: hello@regdatalab.com.